VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171,503,194 | +2.1% | 3,364,127 | 0.0% | 0.05% | +4.4% |
| Q2 2023 | $168,004,502 | +57.1% | 3,364,127 | +17.9% | 0.04% | +45.2% |
| Q1 2023 | $106,930,665 | -20.5% | 2,853,006 | +1.7% | 0.03% | -24.4% |
| Q4 2022 | $134,547,796 | +961.2% | 2,806,002 | +445.0% | 0.04% | +925.0% |
| Q3 2022 | $12,679,000 | – | 514,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $82,124,000 | 28.36% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $37,277,000 | 21.71% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,405,421 | $27,757,000 | 8.90% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $45,614,000 | 3.66% |
| RA Capital Management | 3,865,808 | $76,350,000 | 1.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 4,558,475 | $90,030,000 | 1.05% |
| Soleus Capital Management, L.P. | 293,650 | $5,800,000 | 1.04% |
| Opaleye Management Inc. | 357,800 | $7,067,000 | 1.04% |
| SABBY MANAGEMENT, LLC | 178,992 | $3,535,000 | 0.69% |
| Penn Mutual Asset Management | 22,227 | $439,000 | 0.50% |